CMTTdb

An integrated database for cancer molecular targeted thearpies

View Agent


Agent Info
Agent:amuvatinib
Synonyms:NA
Drug Status For Certain Diseases:NA
Classification:a novel orally administered tyrosine kinase inhibitor with in vitro pharmacological activity against mutant KIT, platelet-derived growth factor receptor alpha (PDGFRα), and Rad51
Target:mutant KIT
platelet-derived growth factor receptor alpha (PDGFRα)
and Rad51
KEGG Pathway:NA
Wiki Pathway:NA